PML RARA T1517Q22Q12 Gene Rearrangement Quantitative PCR Test
Introduction
The PML RARA T1517Q22Q12 Gene Rearrangement Quantitative PCR Test is a vital diagnostic tool used in the field of molecular diagnostics, particularly for identifying certain types of leukemia. This test focuses on detecting the PML-RARA fusion gene, which is commonly associated with acute promyelocytic leukemia (APL). Early detection of this genetic alteration is crucial for effective treatment planning and improving patient outcomes.
What the Test Measures
This test employs Real Time PCR technology to quantitatively measure the presence of the PML-RARA fusion transcript in a patient’s blood sample. The detection of this gene rearrangement is essential for confirming a diagnosis of APL, enabling oncologists to tailor specific therapeutic strategies.
Who Should Consider This Test
Patients who exhibit symptoms of leukemia, such as unexplained fatigue, frequent infections, or unusual bleeding, should consider this test. Additionally, individuals with a family history of leukemia or those who have previously been diagnosed with other forms of cancer may also benefit from this test.
Benefits of Taking the Test
- Accurate diagnosis of acute promyelocytic leukemia.
- Guidance for personalized treatment options.
- Early detection can lead to better management and outcomes.
- Non-invasive testing method with a quick turnaround time.
Understanding Your Results
Results from the PML RARA T1517Q22Q12 Gene Rearrangement Test will indicate the presence or absence of the PML-RARA fusion gene. A positive result confirms the diagnosis of APL, while a negative result may suggest alternative conditions. It is essential to discuss your results with your oncologist for comprehensive understanding and next steps.
Test Name and Price
| Price Type | Amount (NGN) |
|---|---|
| Discount Price | 150,000 NGN |
| Regular Price | 240,000 NGN |
Booking the Test
To book the PML RARA T1517Q22Q12 Gene Rearrangement Quantitative PCR Test, please contact us at +2348110567037 or visit our website. Ensure you complete the Duly filled Genomics Clinical Information Requisition Form (Form 20) before your appointment.
Sample Requirements
The test requires a sample of 5 mL (minimum 3 mL) of whole blood collected in two Lavender Top (EDTA) tubes. The sample must be shipped refrigerated and should not be frozen.
Turnaround Time
Samples are accepted on Monday, Wednesday, and Friday by 9 AM, with reports available on Tuesday, Thursday, and Saturday.
